Related Experiment Video
Updated: May 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Clinical features and gene analyses of six patients with MYH9-related disease]
Xiong-hua Sun1, Zhao-yue Wang, Li-juan Cao
1Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Lab of Thrombosis and Hemostasis of Minstry of Health, Suzhou 215006, China.
Insights
Genetic mutations in the nonmuscle myosin heavy chain 9 gene (MYH9) cause MYH9-related disease, characterized by thrombocytopenia with giant platelets. This study identified novel MYH9 mutations in affected patients, highlighting the gene
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- MYH9-related disease is a spectrum of inherited disorders.
- Clinical presentation includes macrothrombocytopenia, leukocyte inclusions, and potential renal and ocular abnormalities.
Observation:
- Six patients with MYH9-related disease were analyzed.
- Clinical features included thrombocytopenia, giant platelets, and granulocyte inclusions.
- Genetic analysis focused on the nonmuscle myosin heavy chain 9 gene (MYH9).
Findings:
- Four mutations in the MYH9 gene were identified in the six patients.
- Two novel mutations, T97C (W33R) and 4335InsCAGAAGAAG (1445InsQKK), were discovered.
- The identified mutations were confirmed through DNA sequencing and polymorphism analysis.
Implications:
- Genetic confirmation of MYH9 mutations is crucial for diagnosing MYH9-related disease.
- Novel mutations expand the known mutation spectrum for MYH9-related disorders.
- Consider MYH9-related disease in persistent, treatment-resistant thrombocytopenia cases.
Objective:
To investigate clinical features and to identify gene mutations in six patients with nonmuscle myosin heavy chain 9 gene (MYH9)-related disease.
Methods:
The platelet counts were measured using automated complete blood cell counter and manual manner. The size of platelets and inclusion bodies were observed under light microscopy. All the 40 exons and exon-intron boundaries of MYH9 gene were amplified by PCR and then DNA sequencing was performed. Restriction endonuclease analysis and polyacrylamide gel electrophoresis (PAGE) were used for polymorphism analysis.
Results:
Six patients all shared the common features of thrombocytopenia with giant platelets and granulocyte inclusions. Four MYH9 gene mutations were found in the six patients: T97C (W33R) in exon 1, 4335Insert CAGAAGAAG (1445InsQKK) and G4269A (D1424N) in exon 30 and G5833T (E1945Stop) in exon 40. The former two were novel mutations which have not been reported in the literature. The results of restriction endonuclease analysis and PAGE could exclude the possibility of nucleotide polymorphisms.
Conclusions:
The MYH9 gene mutations were identified in six patients with MYH9 related disorders, and T97C (W33R) and 4335InsCAGAAGAAG (1445InsQKK) were novel mutations. MYH9 related disease should be considered in individuals with persistent thrombocytopenia which is non-responsive to corticosteroids and immuno-repressive agents.
More Related Videos
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Huntington Disease l: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pleiotropy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies